MET and head and neck squamous cell carcinoma: A meta-analysis including published clinical data from 1724 patients with HNSCC found a significant association of increased MET gene expression with poor overall survival while immunohistochemical staining demonstrated a significant increased association of c-MET protein expression with worse relapse-free survival and the presence of regional lymph node metastasis [32].